Technical Analysis for KARBF - Karo Pharma Aktiebolag

Grade Last Price % Change Price Change
grade B 6.31 16.85% 0.9100
KARBF closed up 16.85 percent on Monday, July 6, 2020, on 62 percent of normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical KARBF trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing High Bullish 16.85%
Narrow Range Bar Range Contraction 16.85%
New 52 Week High Strength 16.85%
Gapped Up Strength 16.85%
New 52 Week Closing Low Bearish 58.15%
Hot IPO Pullback Bullish Swing Setup 58.15%
Older signals for KARBF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Karo Pharma AB (publ), a healthcare company, develops and markets products for pharmacies and the health care sectors in Sweden, Norway, Denmark, and Finland. The company's development projects are focused on nuclear receptors as target proteins for the development of pharmaceuticals. Its products include Mabs medical compression socks to enhance blood circulation in the legs; Allévo nutritional products; Swereco ergonomic products for people with disabilities; and Dosett medicine storage products. The company also offers Triolif, an over-the-counter medicine for the treatment of sore throats; Vagisan, an over-the-counter product for the treatment of vaginal dryness for women; Plantur 39 for the treatment of hair; Slicks stockings and tights for legs; and BabySlide, a product to reduce lacerations during childbirth, as well as medicines for the treatment of pains, such as headache, toothache, menstrual pain, muscle pain, and joint pain. Its products under development include nuclear receptor RORgamma based products for the treatment of autoimmune diseases; compounds to treat multiple sclerosis and cancer; and T268A, a common cold spray. Karo Pharma AB (publ) markets and distributes its products through the retail market, health specialist stores, and convenience stores. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was founded in 1987 and is headquartered in Stockholm, Sweden.
Healthcare Cancer Pharmaceuticals Pharmaceutical Industry In China Pain Pharmaceuticals Policy Autoimmune Diseases Nutritional Products Multiple Sclerosis Science And Technology In The People's Republic Of China Joint Pain Headache Pains Pharmacy In China Retail Market Treatment Of Autoimmune Diseases Sore Throats

Is KARBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.31
52 Week Low 3.95
Average Volume 1,625
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.3100
Resistance 3 (R3) 6.3100 6.3100 6.3100
Resistance 2 (R2) 6.3100 6.3100 6.3100 6.3100
Resistance 1 (R1) 6.3100 6.3100 6.3100 6.3100 6.3100
Pivot Point 6.3100 6.3100 6.3100 6.3100 6.3100
Support 1 (S1) 6.3100 6.3100 6.3100 6.3100 6.3100
Support 2 (S2) 6.3100 6.3100 6.3100 6.3100
Support 3 (S3) 6.3100 6.3100 6.3100
Support 4 (S4) 6.3100